IPAImmunoPrecise Antibodies Ltd.

Nasdaq ipatherapeutics.com


$ 0.65 $ -0.02 (-2.81 %)    

Monday, 09-Sep-2024 15:46:30 EDT
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 0.6507
$ 0.65
$ 0.64 x 100
-- x --
$ 0.65 - $ 0.66
$ 0.58 - $ 2.60
33,552
na
17.53M
$ 3.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reported-friday-immunoprecise-antibodies-receives-nasdaq-deficiency-notification-for-falling-below-100-bid-price-threshold

The Notification Letter is only a notification of deficiency, it is not a notice of imminent delisting, and it has no current i...

 benchmark-maintains-speculative-buy-on-immunoprecise-antibodies-lowers-price-target-to-3

Benchmark analyst Robert Wasserman maintains ImmunoPrecise Antibodies (NASDAQ:IPA) with a Speculative Buy and lowers the pri...

 hc-wainwright--co-reiterates-buy-on-immunoprecise-antibodies-maintains-9-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ImmunoPrecise Antibodies (NASDAQ:IPA) with a Buy and maint...

 benchmark-reiterates-speculative-buy-on-immunoprecise-antibodies-maintains-5-price-target

Benchmark analyst Robert Wasserman reiterates ImmunoPrecise Antibodies (NASDAQ:IPA) with a Speculative Buy and maintains $5 ...

 hc-wainwright--co-reiterates-buy-on-immunoprecise-antibodies-maintains-9-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ImmunoPrecise Antibodies (NASDAQ:IPA) with a Buy and maint...

 immunoprecise-antibodies-q3-2024-gaap-eps-008-beats-010-estimate-sales-4555m-miss-6068m-estimate

ImmunoPrecise Antibodies (NASDAQ:IPA) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate ...

 earnings-scheduled-for-march-14-2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

 why-highpeak-energy-shares-are-trading-lower-by-15-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-exp...

 ipas-subsidiary-biostrand-unveils-major-breakthrough-in-life-sciences-with-advanced-foundation-ai-model-utilizing-llm-stacking-and-hyft-technology

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ:IPA), an artificial intelligence-driven bi...

 immunoprecise-antibodies-reports-a-199-revenue-increase-as-it-launches-the-next-phase-of-lensai-portal-and-saas-platforms-in-the-recent-quarter-the-company-achieved-revenues-of-cad62-million

ImmunoPrecise Antibodies (NASDAQ:IPA) ("IPA"), a leading company in AI-driven biotherapeutic research and technology, h...

 immunoprecise-antibodies-q2-eps-007-beats-010-estimate-sales-462m-beat-433m-estimate

ImmunoPrecise Antibodies (NASDAQ:IPA) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION